Published in Hear Res on November 22, 2005
A quantitative comparison of the influence of individual versus population-derived vascular input functions on dynamic contrast enhanced-MRI in small animals. Magn Reson Med (2011) 1.18
Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology. Neoplasia (2012) 1.10
Steroid control of acute middle ear inflammation in a mouse model. Arch Otolaryngol Head Neck Surg (2009) 1.05
Corticosteroid therapy for hearing and balance disorders. Anat Rec (Hoboken) (2012) 1.02
Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids. Otolaryngol Head Neck Surg (2008) 0.93
Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers. Mol Pharm (2010) 0.92
The role of aldosterone blockade in murine lupus nephritis. Arthritis Res Ther (2008) 0.88
Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis. Parasitol Res (2011) 0.87
Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg (2008) 0.87
Endolymphatic sodium homeostasis by extramacular epithelium of the saccule. J Neurosci (2009) 0.84
Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy (2009) 0.82
Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss. Audiol Neurootol (2009) 0.82
Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice. Eur Arch Otorhinolaryngol (2011) 0.78
Low dose combination steroids control autoimmune mouse hearing loss. J Neuroimmunol (2010) 0.77
Expression and dexamethasone-induced nuclear translocation of glucocorticoid and mineralocorticoid receptors in guinea pig cochlear cells. Hear Res (2013) 0.77
Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A. J Negat Results Biomed (2016) 0.75
Age-related hearing loss: prevention of threshold declines, cell loss and apoptosis in spiral ganglion neurons. Aging (Albany NY) (2016) 0.75
Intratympanic dexamethasone injections for refractory Meniere' s disease. Int J Clin Exp Med (2015) 0.75
An overview of pharmacology and clinical aspects concerning the therapy of cochleo-vestibular syndromes by intratympanic drug delivery. Clujul Med (2013) 0.75
Advances in Auditory and Vestibular Medicine. Audiol Med (2009) 0.75
Relationship of glucocorticoid receptor expression in peripheral blood mononuclear cells and the cochlea of guinea pigs and effects of dexamethasone administration. PLoS One (2013) 0.75
Evaluation of the mouse model for acute otitis media. Hear Res (2006) 1.32
C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope (2006) 1.20
Altered expression of middle and inner ear cytokines in mouse otitis media. Laryngoscope (2011) 1.19
Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol (2006) 1.10
Cochlear cytokine gene expression in murine acute otitis media. Laryngoscope (2007) 1.09
Steroid control of acute middle ear inflammation in a mouse model. Arch Otolaryngol Head Neck Surg (2009) 1.05
Cochlear cytokine gene expression in murine chronic otitis media. Otolaryngol Head Neck Surg (2007) 1.03
Simultaneous measurement of multiple ear proteins with multiplex ELISA assays. Hear Res (2010) 1.02
Gram-negative pathogen Klebsiella oxytoca is associated with spontaneous chronic otitis media in Toll-like receptor 4-deficient C3H/HeJ mice. Acta Otolaryngol (2008) 0.99
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila) (2009) 0.97
Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids. Otolaryngol Head Neck Surg (2008) 0.93
Anatomical analysis of transoral surgical approaches to the clivus. J Neurosurg (2006) 0.92
Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality. Arch Otolaryngol Head Neck Surg (2010) 0.91
Invasive fungal rhinosinusitis: a 15-year experience with 29 patients. Laryngoscope (2013) 0.90
Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice. Hear Res (2006) 0.89
Hearing loss in the laminin-deficient dy mouse model of congenital muscular dystrophy. Mol Genet Metab (2002) 0.89
Outcome of craniofacial resection in patients 70 years of age and older. Head Neck (2007) 0.88
Reconstruction of the jejunoesophageal anastomosis with a circular mechanical stapler in total laryngopharyngectomy defects. Head Neck (2011) 0.88
Evidence-based practice: management of the clinical node-negative neck in early-stage oral cavity squamous cell carcinoma. Otolaryngol Clin North Am (2012) 0.87
Mouse middle ear ion homeostasis channels and intercellular junctions. PLoS One (2012) 0.86
Surgeon experience and complications with Transoral Robotic Surgery (TORS). Otolaryngol Head Neck Surg (2013) 0.85
Robotic surgery for primary head and neck squamous cell carcinoma of unknown site. JAMA Otolaryngol Head Neck Surg (2013) 0.85
Inner ear tissue remodeling and ion homeostasis gene alteration in murine chronic otitis media. Otol Neurotol (2013) 0.85
Otitis media impacts hundreds of mouse middle and inner ear genes. PLoS One (2013) 0.84
The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma: a current review. Curr Oncol Rep (2015) 0.84
Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck (2011) 0.84
Tuberculosis of the nasolacrimal duct. Ophthal Plast Reconstr Surg (2011) 0.83
Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss. Audiol Neurootol (2009) 0.82
False-negative sentinel lymph node biopsy in head and neck melanoma. Otolaryngol Head Neck Surg (2011) 0.82
Individualized estimation of conditional survival for patients with head and neck cancer. Otolaryngol Head Neck Surg (2011) 0.81
Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice. Laryngoscope (2002) 0.80
Female MRL.MpJ-Fas(lpr) autoimmune mice have greater hearing loss than males. Hear Res (2002) 0.80
Venous thromboembolism in patients with head and neck cancer after surgery. Head Neck (2012) 0.79
Low dose combination steroids control autoimmune mouse hearing loss. J Neuroimmunol (2010) 0.77
Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs. Acta Otolaryngol (2013) 0.77
An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy. JAMA Otolaryngol Head Neck Surg (2013) 0.76
Prospective study of venous thromboembolism in patients with head and neck cancer after surgery: interim analysis. JAMA Otolaryngol Head Neck Surg (2013) 0.76
Hybrid Capture 2 is as effective as PCR testing for high-risk human papillomavirus in head and neck cancers. Appl Immunohistochem Mol Morphol (2015) 0.75
Modified ileocolic free flap: viable choice for reconstruction of total laryngopharyngectomy with total glossectomy. Head Neck (2009) 0.75
Metastatic papillary thyroid carcinoma presenting as a long-standing calcified neck mass. Thyroid (2007) 0.75
Atelectasis after free rectus transfer and abdominal wall reconstruction. Head Neck (2008) 0.75
Pathology quiz case 1. Coexistent conventional mucoepidermoid carcinoma of the thyroid (MECT) and papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg (2009) 0.75
Infected tracheal diverticulum presenting as a cervical abscess. Otolaryngol Head Neck Surg (2011) 0.75
Radiology quiz case 2. Cervical foregut duplication cyst. Arch Otolaryngol Head Neck Surg (2011) 0.75
Airway reconstruction in Wegener's granulomatosis-associated laryngotracheal stenosis. Laryngoscope (2011) 0.75